Cidara Therapeutics Inc (CDTX)

Dec 10, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Dec 10, 2025

Dec 09, 2025

Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump - The Motley Fool

Dec 09, 2025

Dec 09, 2025

RedChip Companies Congratulates Former Client Cidara Therapeutics on Its $9.2 Billion Acquisition by Merck - Savannah Morning News

Dec 09, 2025

Dec 08, 2025

Best Biotech Stocks To Keep An Eye OnDecember 8th - MarketBeat

Dec 08, 2025

Dec 07, 2025

Cidara Therapeutics (CDTX) price target increased by 18.53% to 220.19 - MSN

Dec 07, 2025

Dec 05, 2025

Is This Pharmaceutical Giant a Buy After a Major Acquisition? - Finviz

Dec 05, 2025

Dec 05, 2025

How Cidara Therapeutics Inc. (20D0) stock behaves under inflation pressureMarket Trend Report & Growth-Oriented Investment Plans - Newser

Dec 05, 2025

Dec 05, 2025

Analysts Shift to Hold as Cidara’s (CDTX) Recent Acquisition Deal Caps Upside - MSN

Dec 05, 2025

Dec 05, 2025

Best Biotech Stocks To ResearchDecember 1st - MarketBeat

Dec 05, 2025

Dec 04, 2025

Cidara Therapeutics (NASDAQ:CDTX) Sets New 1-Year HighStill a Buy? - MarketBeat

Dec 04, 2025

Dec 04, 2025

Cidara Therapeutics Earnings Notes - Trefis

Dec 04, 2025

Dec 03, 2025

Cidara Therapeutics stock hits 52-week high at 220.49 USD By Investing.com - Investing.com South Africa

Dec 03, 2025

Dec 03, 2025

Cidara Therapeutics stock hits 52-week high at 220.49 USD - Investing.com

Dec 03, 2025

Dec 03, 2025

Quadrature Capital Ltd Takes Position in Cidara Therapeutics, Inc. $CDTX - MarketBeat

Dec 03, 2025

Dec 03, 2025

How resilient is Cidara Therapeutics Inc. stock in market downturnsNew Guidance & High Accuracy Trade Signal Alerts - Newser

Dec 03, 2025

Dec 02, 2025

Merck Commits $9.2 Billion to Acquire Cidara Therapeutics - MSN

Dec 02, 2025

Dec 02, 2025

Gainers Report: How resilient is Cidara Therapeutics Inc stock in market downturns2025 Top Gainers & Expert-Curated Trade Recommendations - BỘ NỘI VỤ

Dec 02, 2025

Dec 02, 2025

The American biopharm company Merck plans to raise $8 billion through the sale of bonds - AKM.RU

Dec 02, 2025

Dec 02, 2025

Cidara Therapeutics (NASDAQ:CDTX) Sees Unusually-High Trading VolumeHere's Why - MarketBeat

Dec 02, 2025

Dec 02, 2025

Ensign Peak Advisors Inc Takes $244,000 Position in Cidara Therapeutics, Inc. $CDTX - MarketBeat

Dec 02, 2025

Dec 02, 2025

Will Cidara Therapeutics Inc. (20D0) stock hit Wall Street targetsEarnings Recap Report & AI Driven Stock Price Forecasts - Newser

Dec 02, 2025

Dec 01, 2025

Merck Kicks Off US Dollar Bond Sale to Help Fund Cidara Deal - Bloomberg.com

Dec 01, 2025

Dec 01, 2025

Merck seeks up to US$8 bil in US bond sale tied to Cidara deal — Bloomberg - The Edge Singapore

Dec 01, 2025

Dec 01, 2025

Geode Capital Management LLC Grows Stock Position in Cidara Therapeutics, Inc. $CDTX - MarketBeat

Dec 01, 2025

Dec 01, 2025

Intech Investment Management LLC Acquires Shares of 9,002 Cidara Therapeutics, Inc. $CDTX - MarketBeat

Dec 01, 2025

Nov 30, 2025

Street Watch: Why Cidara Therapeutics Inc. stock attracts high net worth investors - BỘ NỘI VỤ

Nov 30, 2025

Nov 30, 2025

3,783 Shares in Cidara Therapeutics, Inc. $CDTX Bought by Police & Firemen s Retirement System of New Jersey - MarketBeat

Nov 30, 2025

Nov 28, 2025

Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer - AOL.com

Nov 28, 2025

Nov 28, 2025

Biotech Stocks To ConsiderNovember 25th - MarketBeat

Nov 28, 2025

Nov 28, 2025

HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the MergerEXAS, SEE, CDTX, and MRSN - The Malaysian Reserve

Nov 28, 2025

Nov 27, 2025

hVIVO gains validation from Cidara’s takeover; broker calls it a "glowing endorsement" - Proactive Investors

Nov 27, 2025

Nov 27, 2025

Why Cidara Therapeutics Inc. stock attracts high net worth investors2025 Biggest Moves & Entry Point Confirmation Signals - BỘ NỘI VỤ

Nov 27, 2025

Nov 27, 2025

hVIVO PLCMSD to acquire Cidara - Research Tree

Nov 27, 2025

Nov 27, 2025

hVIVO welcomes MSD’s move to acquire Cidara in $9.2 billion deal - Vox Markets

Nov 27, 2025

Nov 27, 2025

hVIVO hails $9.2 billion Cidara takeover after key trial wins - Proactive financial news

Nov 27, 2025

Nov 25, 2025

Cidara Therapeutics (CDTX): Assessing Valuation After a 137% One-Month Surge - Yahoo Finance

Nov 25, 2025

Nov 24, 2025

Top Biotech Stocks To ConsiderNovember 20th - MarketBeat

Nov 24, 2025

Nov 24, 2025

Cidara Therapeutics (CDTX) Completes Enrollment for Crucial Phas - GuruFocus

Nov 24, 2025

Nov 24, 2025

Cidara Therapeutics Meets Target Enrollment for Phase 3 Trial of Potential Flu Preventative - MarketScreener

Nov 24, 2025

Nov 24, 2025

Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations - The Manila Times

Nov 24, 2025

Nov 24, 2025

Cidara Therapeutics Reaches Target Enrollment of Phase 3 - GlobeNewswire

Nov 24, 2025

Nov 23, 2025

Is Cidara Therapeutics Inc a good long term investmentStock Price Divergence & Unlock Long-Term Capital Growth Ideas - earlytimes.in

Nov 23, 2025

Nov 23, 2025

Analysts Shift to Hold as Cidara's (CDTX) Recent Acquisition Deal Caps Upside - Finviz

Nov 23, 2025